Holen Sie sich die Stockscreener-App
1.34
0.00%
0.00
Handel nachbörslich:
1.34
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
60 Degrees Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastFree Trend-Following Techniques - jammulinksnews.com
What drives 60 Degrees Pharmaceuticals Inc. stock priceExceptional profit potential - Autocar Professional
What analysts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockFree Stock Chart Pattern Guide - jammulinksnews.com
What drives 60 Degrees Pharmaceuticals Inc. Equity Warrant stock priceMarket-beating returns - jammulinksnews.com
Is 60 Degrees Pharmaceuticals Inc. a good long term investmentExceptional financial outcomes - Autocar Professional
What analysts say about 60 Degrees Pharmaceuticals Inc. stockHigh-profit trading signals - jammulinksnews.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a good long term investmentExceptional market performance - Autocar Professional
60 Degrees Pharmaceuticals Inc. Stock Analysis and ForecastOutstanding capital appreciation - Autocar Professional
Will 60 Degrees Pharmaceuticals Inc. stock benefit from interest rate changesHigh Return Stock Alerts - Newser
60 Degrees Pharmaceuticals Secures $5M in Recent Offering - TipRanks
How 60 Degrees Pharmaceuticals Inc. stock reacts to Fed policy changesFree Deep Market Trend Analysis - Newser
What risks could impact 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performanceWealth Building Stock Portfolio - Newser
60 Degrees Pharmaceuticals to study tafenoquine against Lyme disease By Investing.com - Investing.com India
60 Degrees Pharmaceuticals Initiates Study on Tafenoquine's Efficacy Against Lyme Disease and Bartonella Pathogens - Nasdaq
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria - The Manila Times
3.32%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):